Kendle to Present at 27th Annual J.P. Morgan Healthcare ... ( CINCINNATI Jan. 7 /- Kendle (Nasd...)

Kendle to Present at 27th Annual J.P. Morgan Healthcare Conference

Date:1/7/2009

CINCINNATI, Jan. 7 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL) a leading, global full-service clinical research organization, today announced Candace Kendle, PharmD, Chairman and CEO, will participate in the 27th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, Jan. 12, 2009 at 4:30 p.m. Pacific Standard Time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO )

The public is invited to listen to a live webcast of Kendle's presentation at http://www.kendle.com (click on the link provided in the Investor Events and Presentations section). An archived version can be accessed approximately three hours following Kendle's presentation and will be available until Feb. 12. Slides accompanying the presentation will be available by 4 p.m. Eastern Standard Time on Jan. 12 at http://www.kendle.com under the Investor Events and Presentations section.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the fastest-growing global providers of Phase I-IV services, we offer experience spanning 90 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers'
'/>"/>

SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Kendle Delivers Record Sales, Net Service Revenues and Earnings Per Share for Second Quarter 2008
2. Kendle Delivers Record Net Service Revenues and New Business Authorizations for First Quarter 2008
3. Kendle Promotes Simon S. Higginbotham to President; Appoints Alan J. Boyce as Chief Marketing Officer
4. Kendle Delivers Strong Growth in Revenues, New Business Authorizations and Operating Margin for Full-Year 2007; Announces Guidance for 2008
5. Kendle Invites You to Attend Its Fourth Quarter and Year End 2007 Earnings Conference Call and Webcast
6. Kendle Appoints Industry Veteran to Lead Asia/Pacific Expansion
7. Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007
8. Kendle Appoints Ken Hintze, PhD, Vice President, Global Clinical Safety & Pharmacovigilance
9. Kendle Executive Dennis Hurley, DrSc to Present Keynote Address at DIA Latin American Congress 2007
10. Medco CEO to Present at the 27th Annual JPMorgan Healthcare Conference
11. BioMarin to Present at the 27th Annual J.P. Morgan Healthcare Conference

Post Your Comments:

(Date:12/2/2009)...wswire-USNewswire/ -- The American Association of ...epin Regional Poison Center in Minneapolis, Minnes...or milestone for the center. The designation by t...r among 58 accredited poison centers in the United...ccomplishment. It means we have met the national s...

(Date:12/2/2009)...RNewswire/ -- Reportlinker.com announces that a ne...ogue: ,, Kinase Inhibitors: Global Markets ...e-Inhibitors-Global-Markets.html ,, Forecast...ars 2005 through 2008, and projections for the mar...gh 2014 ,, An overview of the market for the k...

(Date:12/2/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, Antibiotic Resistance and Antibiotic T...ortlinker.com/p0166825/Antibiotic-Resistance-and-A...Provide an in-depth review of the global market fo...ies ,, Offer an analysis of antibiotics resista...

(Date:12/2/2009)...PRNewswire/ -- The Washington Post reported that C...o Coremetrics, a marketing optimization company, i...mpared to Cyber Monday 2008. ,, Contrast those ...reported today "Cyber Monday website traffic rose ...id Tiffany Amorosino, COO of Bella Sante. ,, ...

(Date:12/2/2009)...y could counter recent increases in longevity , ...e overall health of the U.S. population has improv...ople have quit smoking in droves, but a new study ...e rising obesity rates among Americans don,t level...ng and obesity continue unchanged, the average lif...

[1] Hennepin Regional Poison Center Designated as an Accredited Poison Control Center [1] Reportlinker Adds Kinase Inhibitors: Global Markets [0] Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets [0] The Washington Post Reported That Cyber Monday Website Traffic Rises 8%. Boston's Bella Sante Day Spas Cyber Monday Website Traffic Rises 76%.[0] Health Gains From Lowered Smoking Rates in Jeopardy

...could produce dramatic results, study says, , ...mericans cut just one gram of salt from their dail...heart disease and more than 200,000 fewer deaths o...ricans are using 50 percent more salt than they di...

...d for Their Commitment to Cleanliness , , - Cu...om SDA, NEA, CDC , , , WASHINGTON, March 11 The...chool health through cleaning is now in the spotli...tergent Association (SDA - www.cleaning101.com ),...

... Researchers have revealed a direct relationshi... of Alzheimer,s disease symptoms, raising hopes th...order is within reach. , ...disease symptoms, raising hopes that a diagnostic...

... to deal with market stress, he said , , NEW YORK...s of the market, psychiatrist and trading coach Ar...of the Greenwich Roundtable, a non-profit research...ional traders and portfolio managers and works wit...

...ama is promising major health reform, huge cutback... for health journalists who are trying to report o... report written by Gary Schwitzer, associate profe...ington, D.C. briefing. , A video interview with ...

...1 Citing dangers to overall health, the North Car...na residents to not give up routine dental examina...wnturn. , , "Routine dental examinations can prec...th Carolina ranks 34th in the country in terms of...

Other Medicine News:Health News:Slight Cut in Salt Intake Would Mean Fewer Heart Attacks, Deaths 2 Health News:Slight Cut in Salt Intake Would Mean Fewer Heart Attacks, Deaths 3 Health News:Cleaning for Health: Custodians Honored for Improving School Environment 2 Health News:Cleaning for Health: Custodians Honored for Improving School Environment 3 Health News:Study Suggests Blood Test for Alzheimer's Possible 2 Health News:Study Suggests Blood Test for Alzheimer's Possible 3 Health News:Psychiatrist and Trading Coach Dr. Ari Kiev Addresses Greenwich Roundtable 2 Health News:U of Minnesota professor authors report the state of health care journalism 2 Health News:N.C. Dental Society Urges North Carolinians to Not Forego Dental Care 2

Slight Cut in Salt Intake Would Mean Fewer Heart Attacks, Deaths Cleaning for Health: Custodians Honored for Improving School Environment Study Suggests Blood Test for Alzheimer's Possible Psychiatrist and Trading Coach Dr. Ari Kiev Addresses Greenwich Roundtable U of Minnesota professor authors report the state of health care journalism N.C. Dental Society Urges North Carolinians to Not Forego Dental Care

(Date:12/2/2009).... and HEIDELBERG, Germany, Dec. 2 ...e winners of the "Top 10 Innovations of 2009" by ...equence capture technology for high-throughput seq...ations of invention, vision and utility. ,, T... evaluate a broad range of life science technologi...

(Date:12/2/2009)...ec. 2 American Scientif...ny), announces that the Disintegrator Plus(TM), th...n device (NDD), is in its first production run for...rent demand for home injection prescription drug u...ing of the SB 486 which requires Californian,s t...

(Date:12/2/2009)...nnsylvania, December 2 S...pecialty biopharmaceutical,company, announces that...ticals USA, Inc. ("Teva") over Shire,s supply to T...R. Shire has been supplying Teva with,authorized g...ility to supply,the product had been limited by re...

Breaking Medicine Technology:The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009' 2 World's Only FDA Approved Home Needle Destruction Device is in Production 2 World's Only FDA Approved Home Needle Destruction Device is in Production 3 Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic 2 HMS Holdings Corp to Present at William Blair 29th Annual Growth Stock Conference 48209 1 FYI From Human Genome Sciences 3A GlaxoSmithKline Study Shows GSKs Novel Diabetes Treatment Syncria 28R 29 28Albiglutide 29 Improves Glucose Control 4566 1 FYI From Human Genome Sciences 3A GlaxoSmithKline Study Shows GSKs Novel Diabetes Treatment Syncria 28R 29 28Albiglutide 29 Improves Glucose Control 4566 2 FYI From Human Genome Sciences 3A GlaxoSmithKline Study Shows GSKs Novel Diabetes Treatment Syncria 28R 29 28Albiglutide 29 Improves Glucose Control 4566 3 Common chemotherapy drug triggers fatal allergic reactions 8748 1 Common chemotherapy drug triggers fatal allergic reactions 8748 2 Common chemotherapy drug triggers fatal allergic reactions 8748 3

[0] The Scientist Magazine Recognizes febit's HybSelect(TM) Among the Winners of 'Top 10 Innovations of 2009'[0] World's Only FDA Approved Home Needle Destruction Device is in Production [0] Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic

...ck -, BRISBANE, Australia, Aug. 16 Progen,Pharma...nnounced it has,executed an agreement with Quintil...tion, to utilise their services for a number of cl...nt includes the execution of the,Phase 3 clinical ...of,primary liver cancer (hepatocellular carcinoma)...

... Products Launched within the Last Five Years h...PHILADELPHIA, Aug. 15 Thomson Scientific,part of ...d leading provider,of information solutions to the...y issued its quarterly The Ones-to-Watch report, p...ng drugs to enter each new phase,of clinical devel...

Other Medicine Technology:Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88 2 Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88 3 Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline 2 Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline 3 Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline 4

Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88 Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline

SureStep Benzodiazepines (BZO 300)

AMPII/BAR/BZO300/COC/MAMP/MTD/MOP/THC

AMPII/BZO300/COC/MAMPII/MOP/THC

COC/MAMPII/MOP/THC/AMPII/BAR/BZO300/MTD/TCA

Medicine Products:

SureStep Benzodiazepines (BZO 300)AMPII BAR BZO300 COC MAMP MTD MOP THC AMPII BZO300 COC MAMPII MOP THC COC MAMPII MOP THC AMPII BAR BZO300 MTD TCA

Kendle to Present at 27th Annual J.P. Morgan Healthcare ...( CINCINNATI Jan. 7 /- Kendle (Nasd...),Health